The HIV+Hepatitis Policy Institute and others are requesting that CMS update the HCV screening National Coverage Determination to bring it in line with the 2020 U.S. Preventive Services Task Force recommendation for HCV screening. The current coverage determination only requires Medicare coverage for HCV screening of baby boomers and people at high risk. We are requesting that Medicare should cover screening of everyone between the ages of 18-79, regardless of symptoms or risk group.
Testimony for the Record House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies (FY 2022)
On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2022 Labor, HHS spending bill.
Comments on draft sexually transmitted infections national strategic plan 2021-2025
Thank you for the opportunity to provide comments on the draft Sexually Transmitted Infections National Strategic Plan 2021-2025 (STI Plan). The HIV+Hepatitis Policy Institute is a leading HIV…
Testimony for the Record Senate Labor HHS Appropriations Subcommittee (FY 2021)
On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2021 Labor, HHS spending bill…
HIV+Hepatitis Policy Institute outlines FY2021 appropriations priorities
The HIV+Hepatitis Policy Institute appreciates the work the Senate has been doing over the last several months responding to the COVID-19 pandemic. We thank you for your continued attention to this crisis, particularly as it affects our nation’s public health infrastructure. We are very appreciative…